Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Europe hasn't"


4 mentions found


Snow covered transfer lines are seen at the Dominion Cove Point Liquefied Natural Gas (LNG) terminal in Lusby, Maryland March 18, 2014. The November figure will also be a slight increase from the 21.41 million metric tons from the same month last year. India, Asia's fourth-biggest LNG buyer, is expected to import 1.3 million metric tons in November, down from 1.85 million in October. More U.S. LNG is also heading to Asia, with November imports slated at 1.97 million metric tons, up from 1.83 million in October. This leaves the spot price at the mercy of demand, and while there has been some uptick in both Asia and Europe, it hasn't been enough to drive spot prices higher.
Persons: Snow, Gary Cameron, Europe hasn't, Asia's, Diane Craft Organizations: REUTERS, Rights, world's, LNG, U.S, Reuters, Thomson Locations: Lusby , Maryland, Rights LAUNCESTON, Australia, Asia, Europe, United States, October's, China, Japan, India, Russia, Ukraine, Qatar, U.S, Western Australia
Big Pharma and biotech companies often outsource clinical trials to external companies. Europe's early-stage clinical trials startups are flush with funds but they're struggling to grow. The fate — and market cap — of a biotech company often lies with a successful clinical trial. The COVID-19 pandemic also spotlighted another promising alternative to carry out these trials — startups. While the US touts around a dozen clinical trials unicorns valued at $1 billion or higher, per Dealroom estimates, Europe's startups are lagging behind.
Persons: BEN, Janssen, Christoph Ruedig, Maya Zlatanova, Europe hasn't, Matt Wilson, Wilson, Christoph Massner, it's, Ruedig Organizations: Big Pharma, pharma, Janssen Pharmaceuticals, Tempus, Venture, Albion VC, US, Earlybird Ventures Locations: Europe, New York, American
But recent data and upbeat comments from major companies like LVMH (LVMH.PA), Europe's most valuable listed company, about business in China have given investors some cause for optimism. Refinitiv I/B/E/S data points to a 2.5% decline in earnings growth in the first quarter for STOXX 600 (.STOXX) companies, down from a forecast for 5.4% growth prior to the banking chaos. Europe is headed for a recession too, the data shows, with a drop in earnings of 5.4% expected in the second quarter. But stubbornly high inflation means major central banks are expected to continue to hike rates, at least in May. European financials are expected to report first-quarter earnings growth of 31%, according to Refinitiv.
The European Commission, the EU's executive arm, published its so-called "Green Claims Directive" on Wednesday. The highly anticipated proposal seeks to establish an EU-wide methodology that will help to clean up the environmental claims marketplace. Today, most green claims are too good to be true and the proposal is… far from the real (green) deal. The EU's "Green Claims Directive" seeks to tackle this trend. "Green claims are everywhere: ocean-friendly t-shirts, carbon-neutral bananas, bee-friendly juices, 100% CO2-compensated deliveries and so on," said Frans Timmermans, executive vice-president for the European Green Deal.
Total: 4